tirzepatide presentation SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity Preliminary results on the Tirzepatide

What we are seeing now is their additional benefit for treating obesity as a metabolic disease, not just a number on the scale

Tirzepatide works gradually, giving your body time to adjust and avoid overwhelming side effects like nausea

Symptoms of SBS include: Headaches Dizziness Fatigue Chest pain Respiratory issues Flu-like symptoms Recent research has linked long-term mold exposure to dysregulation of the immune system, increasing your risk of infectious diseases, and it can even lead to serious neurodegenerative brain disorders like Parkinsons disease

Retatrutide is investigated in laboratory and clinical research for its simultaneous interaction with three receptors involved in metabolic signalling: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor

Each online consultation is reviewed individually by one of our prescribing clinicians who will advise you on the most suitable dose for you